FridayOct 30, 2020 2:20 pm

QualityStocksNewsBreaks – Pure Extracts Technologies Inc. Leveraging Growing Acceptance of ‘Nature’s Miniature Pharmaceutical Factories’

Pure Extracts, a private, plant-based extraction company, is leveraging growing acceptance by mainstream science and the general public to further develop and commercialize functional and medicinal mushroom products on a global scale. World-renowned mycologist Paul Stamets describes mushrooms as “nature’s miniature pharmaceutical factories” (https://ibn.fm/wbYSa). Studied extensively for their various health benefits, current research suggests different varieties of mushrooms may help to improve memory (https://ibn.fm/KUHQ3), mental cognition (https://ibn.fm/dNuo4) and to alleviate the symptoms of depression (https://ibn.fm/YCMQK). Further, “Psychedelic” varieties such as psilocybin – or “magic mushrooms” – are increasingly being studied for possible medical benefits in treating depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease and…

Continue Reading

MondayOct 26, 2020 10:11 am

Medicinal Mushrooms Booming, Pure Extract Technologies Inc. First-Mover Strategy Catalyzing Growth

Research indicates that functional and medicinal mushrooms offer range of physical and mental benefits Pure Extracts’ milestone-based strategy catalyzing Company growth Strategy includes license procurement, production, marketing of in-house and white label products Mainstream science is now catching up with what traditional medicine has known for years — that functional and medicinal mushrooms can help treat disease, improve mental cognition and fire up digestion. Pure Extract Technologies Inc., a soon-to-be public, plant-based Canadian extraction company, is on track to position itself as an industry leader through a strategy based on three growth-focused milestones that include the application to Health Canada…

Continue Reading

FridayOct 23, 2020 1:29 pm

Pure Extract Technologies Inc.’s Three-Pillar Business Model Points Company Toward Success

‘Harvard Business Review’ cites importance of a good business model, specifies key questions it should answer. Pure Extracts’ business model founded on three pillars: extraction services, formulation & white-labeling, and development of its in-house ‘Pure Pulls’ branded cannabis and functional mushroom products. Company’s business model is multi-faceted, comprehensive and allows for future growth. A strong business model is essential to every successful organization, whether it’s a new venture or an established player, touts a “Harvard Business Review” article titled “Why Business Models Matter.” Pure Extracts Technologies Corp., a plant-based extraction company with a new vertical in functional mushrooms, recognizes the…

Continue Reading

TuesdayOct 20, 2020 1:37 pm

QualityStocksNewsBreaks – Pure Extract Technologies Inc. Looks to Production of Highest-Quality FSO

Pure Extract, a private, plant-based extraction company, was recently awarded a Standard Processing License by Health Canada under the Cannabis Act. Following this significant milestone, Pure Extracts will now proceed with application to Health Canada for a Natural Health Products Site License at its purpose-built extraction facility while adhering to EU Good Manufacturing Practices (“GMP”). This will help to enable the company to extract its full spectrum oil (“FSO”) to the highest-possible quality. “We are thrilled to be commencing production in our new, EU-GMP compliant, purpose-built facility,” stated Pure Extracts founder and COO Doug Benville in a recent article discussing…

Continue Reading

WednesdayOct 14, 2020 3:25 pm

QualityStocksNewsBreaks – Pure Extract Technologies Inc. Eyes Opportunity as Psilocybin Shows Promise for Treating Depression

Pure Extract Technologies, a private, plant-based extraction company, is positioned for opportunity as interest grows in the psychedelic and functional mushrooms sector. Recent groundbreaking research indicates that psilocybin-assisted psychotherapy may be effective in treating depression, a debilitating disorder that plagues an estimated 300 million people across the United States. According to a recent National Centre for Mental Health (“NCMH”) article, “a small number of studies have been conducted trialing psilocybin on patients with treatment-resistant depression.” Test results showed a significant decrease in depression scores after only one week to three months, with the majority of participants experiencing reduced depression severity…

Continue Reading

WednesdayOct 14, 2020 1:10 pm

Pure Extract Technologies Inc. Leveraging Growing Popularity of Medicinal Mushrooms in Mainstream Medicine

Scientific research suggests some mushrooms can provide mental benefits, anti-tumor effects, improved immune function, anti-viral properties and detoxification “Psychedelic” varieties currently being studied for depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease, addiction Pure Extracts is expanding into functional mushroom market; Company is currently licensed by Health Canada to buy, sell, produce cannabis products Mushrooms have been used for thousands of years in Eastern medicine to combat illness, increase mental cognition and improve digestion. As their popularity continues to increase worldwide, Pure Extract Technologies, a privately held, plant-based, Canadian extraction company is leveraging the growing acceptance by mainstream science and the…

Continue Reading

MondayOct 12, 2020 2:10 pm

Pure Extract Technologies Awarded Standard Processing License by Health Canada, Eyes Expansion Plans

Pure Extract Technologies has been awarded Standard Processing License by Health Canada The license will enable the Company to produce, sell cannabis & hemp products to other Licenced Producers in its purpose-built facility located near Whistler, Canada Canada’s ability to export worldwide coupled with Company’s EU-GMP compliant facility makes Pure Extracts a natural partner for companies involved within international distribution Pure Extract Technologies, a privately held British Columbia-domiciled plant extraction company, announced that it had been awarded a Standard Processing Licence by Health Canada under the Cannabis Act, following an extensive and meticulous five-month application and vetting process (https://ibn.fm/xElDa). Pure Extracts…

Continue Reading

ThursdayOct 08, 2020 1:17 pm

QualityStocksNewsBreaks – Pure Extract Technologies Inc. Positioning as Research Looks to the ‘Magic’ in Mushrooms

Pure Extract Technologies, a private, plant-based extraction company, is positioning for opportunity amid the ramping up of next-generation research regarding potential benefits of functional mushrooms and psilocybin compounds. The company is pursuing a Natural Health Products Site License from Health Canada to buy, sell and produce functional mushroom products in an EU-GMP-compliant environment. This will position Pure Extracts to partner with organizations that plan to develop both functional and psychedelic products. The timing appears optimal as further studies aim to explore the benefits of psychedelics, including potential anti-tumor effects, improved immune function, mental wellness, detoxification and more. A recent article…

Continue Reading

FridayOct 02, 2020 12:12 pm

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in Rapidly Growing Mushroom Space

Research shows psilocybin produces immediate, substantial and sustained improvements in anxiety and depression Global medicinal mushroom market projected to increase by almost $14 billion annually for the next several years Pure Extracts is a plant-based extraction company with new vertical in the mushroom space Recent groundbreaking research indicates that psilocybin-assisted psychotherapy may be effective in treating depression, a debilitating disorder that plagues an estimated 300 million people in the United State. Psilocybin is the main psychoactive ingredient in “magic” mushrooms. With growing interest in the mushroom sector — both psychedelic and functional — companies such as Pure Extract Technologies could see exciting…

Continue Reading

WednesdaySep 30, 2020 2:30 pm

Pure Extract Poised to Benefit as Mainstream Society Embraces Functional Mushrooms

Following $1.25 million donation, UC Berkeley launching Center for the Science of Psychedelics Pure Extract Technologies Inc. expanding into functional and medicinal mushroom market Psychedelic compounds increasingly being studied to treat wide range of physical, mental conditions Pure Extracts plans to obtain a Natural Health Products Site License from Health Canada to buy, sell, functional mushroom products For hundreds of years, medicinal mushrooms have been revered among both ancient and modern cultures throughout the world for their nutritional and medicinal qualities. Pure Extract Technologies, a private plant-based Canadian extraction company headquartered in British Columbia, is leveraging the latest in science…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered